Literature DB >> 13620852

Separation and characterization of human serum chylomicrons.

A SCANU, I H PAGE.   

Abstract

Chylomicrons were separated by low and high speed ultracentrifugation from lipemic sera of human subjects in the absorptive phase. The final chylomicron preparation was free from other serum components and contained a small constant amount of protein, approximately 2 per cent of the chylomicron fraction. Electrophoresis, immunochemical analysis, and absorption experiments identified the protein component as derived from a mixture of beta and alpha(1) serum lipoproteins. Large aliquots of an emulsion of serum freed of chylomicrons and coconut oil were incubated at 37 degrees C. for 2 hours and ultracentrifuged as in the preparation of chylomicrons. The fat particles now showed the presence of minute amounts of beta and alpha(1) serum lipoproteins in almost the same proportion as found in chylomicrons. "Finger prints" of delipidized samples of chylomicrons and particles from serum-coconut oil emulsion gave similar, although not identical patterns. The data on "clearing factor" activity corroborated the finding that serum alpha(1) lipoproteins are contained in chylomicrons and particles from serum-coconut oil emulsion. These two lipide particles, partially delipidized, were both able to activate a "clearing factor" system in vitro, a property exhibited only by intact or partially delipidized alpha(1) serum lipoproteins. Clearing activity was satisfactorily determined by using an emulsion of coconut oil mixed in agar as a substrate to give an opaque gel, in which the diffusing enzyme showed its activity by areas of clearing. The results obtained by this technique were in agreement with those based on fall in optical density and non-esterified fatty acid production. Chemical analysis of serum chylomicrons showed a concentration of cholesterol and phospholipides higher than could be accounted for by the attached beta and alpha(1) serum lipoproteins. On the basis of these results the assumption is made that in the blood stream small amounts of serum lipoproteins, by a process of adsorption, form a complex with the absorbed triglycerides, cholesterol, and phospholipides, to produce chylomicrons.

Entities:  

Keywords:  FATS/in blood

Mesh:

Substances:

Year:  1959        PMID: 13620852      PMCID: PMC2136949          DOI: 10.1084/jem.109.3.239

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  The chemical composition of chylomicra in the rat.

Authors:  D S ROBINSON
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1955-04

2.  On the composition of chyle chylomicrons.

Authors:  J H BRAGDON
Journal:  J Lab Clin Med       Date:  1958-10

3.  Clearing factor, a heparin-activated lipoprotein lipase. II. Substrate specificity and activation of coconut oil.

Authors:  E D KORN
Journal:  J Biol Chem       Date:  1955-07       Impact factor: 5.157

4.  Plasma proteins and fat transport in dogs.

Authors:  R L SWANK; J H FELLMAN
Journal:  Am J Physiol       Date:  1958-02

5.  N-terminal residues of serum lipoproteins.

Authors:  J AVIGAN; R REDFIELD; D STEINBERG
Journal:  Biochim Biophys Acta       Date:  1956-06

6.  The ultracentrifugal characterization and isolation of human blood lipids and lipoproteins, with applications to the study of atherosclerosis.

Authors:  F T LINDGREN; H A ELLIOTT; J W GOFMAN
Journal:  J Phys Colloid Chem       Date:  1951-01

7.  The phenomenon of chylomicrons in fat absorption and arteriosclerosis.

Authors:  H NECHELES
Journal:  Am J Dig Dis       Date:  1951-08

8.  A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity.

Authors:  L L ABEL; B B LEVY; B B BRODIE; F E KENDALL
Journal:  J Biol Chem       Date:  1952-03       Impact factor: 5.157

9.  Studies on the antigenicity of beta- and alpha-lipoproteins of human serum.

Authors:  A SCANU; L A LEWIS; I H PAGE
Journal:  J Exp Med       Date:  1958-08-01       Impact factor: 14.307

10.  The antigenic similarity of human low density lipoproteins.

Authors:  L LEVINE; D L KAUFFMAN; R K BROWN
Journal:  J Exp Med       Date:  1955-08-01       Impact factor: 14.307

View more
  5 in total

1.  Plasma transport of lipids and lipoprotein proteins in dogs treated with triton WR-1339.

Authors:  A SCANU; I H PAGE
Journal:  J Clin Invest       Date:  1962-03       Impact factor: 14.808

2.  Ultracentrifugal isolation of serum chylomicron-containing fractions with quantitation by infrared spectrometry and NCH elemental analysis.

Authors:  F T Hatch; N K Freeman; L C Jensen; G R Stevens; F T Lindgren
Journal:  Lipids       Date:  1967-03       Impact factor: 1.880

3.  ESTIMATION OF THE LOW-DENSITY (BETA) LIPOPROTEINS OF SERUM IN HEALTH AND DISEASE USING LARGE MOLECULAR WEIGHT DEXTRAN SULPHATE.

Authors:  K W WALTON; P J SCOTT
Journal:  J Clin Pathol       Date:  1964-11       Impact factor: 3.411

4.  Apoproteins in association with Intralipid incubations in rat and human plasma.

Authors:  S F Robinson; S H Quarfordt
Journal:  Lipids       Date:  1979-04       Impact factor: 1.880

5.  Effects of Lactobacillus plantarum Q180 on Postprandial Lipid Levels and Intestinal Environment: A Double-Blind, Randomized, Placebo-Controlled, Parallel Trial.

Authors:  Ye Eun Park; Min Seo Kim; Kyung Won Shim; You-Il Kim; Jaeryang Chu; Byoung-Kook Kim; In Suk Choi; Ji Yeon Kim
Journal:  Nutrients       Date:  2020-01-19       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.